Ben Stiller Remembers Robin Williams: 'He Represented What It Meant To Be Funny'

The following article is provided by Rolling Stone.

By JAMES MONTGOMERY

Robin Williams’ career spanned five decades, beginning on the tiny stages of comedy clubs and subsequently expanding to television and feature films. He worked with comedians on their way up, actors who had already reached the heights of fame and seemingly everyone in between.

So as news of his death began to spread on Monday, it’s not surprising that so many of Hollywood’s biggest names paid tribute to Williams’ talents, his generosity and his creativity. Some had met him only briefly, while others, like actor Ben Stiller, shared the screen with him in the “Night at the Museum” franchise (the third installment, which features Williams reprising his role as Teddy Roosevelt, will hit theaters in December) and knew the comedian for years.

Robin Williams a Roots Fan? Questlove Recalls an Unlikely Admirer

In a statement to Rolling Stone, Stiller recalls the first time he ever met Williams, which didn’t occur on set, but rather, at a legendary comedy club, when Stiller was still too young to take the stage himself.

Robin Williams: Chevy Chase, Danny DeVito and More Pay Homage

“I met Robin when I was 13 at the Improv. I was there with my parents who were maybe performing and it was crowded and I heard this voice behind me saying ‘Stay close to your mother, you’ll be safe! Stay close to your mother, you’ll be safe!” Stiller writes. “I turned around and it was Robin. For a 13 year old who was a huge ‘Mork & Mindy’ fan, it was sort of like the end of the world. I never forgot it.

Robin Williams: Fears of a Clown

“So working with him years later I always had this little voice inside of me going ‘You are acting with Robin Williams! This is the coolest thing ever!'” he continues. “I never got over being a fan. I think most people my age have the same feeling – that he and Steve Martin and Bill Murray sort of represented what it meant to be funny.”

Peter Travers on 9 of His Favorite Robin Williams Performances

But beyond Williams’ abilities to make people laugh, Stiller writes that he’ll always remember his heart, which, like the man itself, was larger than life.

Robin Williams’ 13 Funniest Impressions

“His kindness and generosity is what I think of. How kind he was to anyone who wanted to connect with him. And he could not help but be funny all the time. He would do something as long as it would keep you laughing,” he writes. “He made many, many film crews laugh out loud before the audiences ever saw it. He made such a big impact on the world. So there is the man, and his talent and I think in his case both were extraordinary.”

Why Do Leafs Fans Hate the Leafs?

When did we enter a world where a fan can’t say something optimistic about their team without fear of backlash? I have been a Leaf fan my whole life and apart from a slight resurgence when I was five when Cliff Fletcher brought in Doug Gilmour and Dave Andreychuk and the call-up Felix Potvin lead the team to a 99-point season, I haven’t experienced many positive outcomes. But I am still a fan, through thick and thin (mostly thin, very thin).

And whether it be here, online, or in a bar talking to friends, I am always shocked at the overt and outward disgust people have when you try to defend or find morsels of optimism in the Leafs. And I expect this from non-Leaf fans — Habs, Canucks, Flames, Sens, etc. fans have always hated the Leafs as we get most of the TV coverage, the coveted 7 p.m. HNIC time slot, etc. But Leaf fans won’t hesitate to throw overt shade.

I understand having your backs up and being on the defensive, there hasn’t been much to celebrate or be proud of in the past 15 years. It can be disappointing to finally get a line that can produce goals (Alexander Mogilny, Mats Sundin and Gary Roberts for example) just to see the rest of the team and the goaltenders fall apart and provide no support.

The Red Sox have some of the most loyal and devout fans in the sporting world and they went over 80 years without winning a World Series. Sure they put on a good show most seasons with some big name players and often a playoff appearance. So is that what Toronto fans are looking for? Quality games? It is often criticized that the Leafs especially, cater to a corporate crowd in a rich market and don’t have the priority of quality players, games, hockey. Which I understand, and I agree, that should be a huge priority. But when CuJo and Sundin left the Leafs to join an organization better equipped to play quality hockey, we selfishly faulted them for it — even though we weren’t producing quality hockey here in Toronto.

What would make us, as Toronto fans, happy? Making the playoffs? One year, two years? First round? Second round? A Cup? There is so much positive press out there for Toronto being a huge market that could support two NHL teams… I suppose they mean financially support two teams, cause the way I see it — we can’t mentally or emotionally support the team we have.

It is fascinating to me as my primary profession is an advertiser that a brand can be so financially successful and continues to see revenue growth, with such ubiquitous negative press and public opinion. It’s like tequila — no one likes the taste, or the way it makes us feel the next morning, but we buy the ticket and go for the ride…

The Ultimate Charles Bronson Movie Trailer

Charles Bronson. Charles Bronson. Charles … BRONSON. Just writing the name puts a few extra hairs on a man’s chest.

Over the course of a 50-year career, Charles Bronson starred in 95 films and made 156 television appearances; including such classics as “The Magnificent Seven,” “The Great Escape,” “Once Upon a Time in the West” and, of course, five “Death Wish” films.

Before Schwarzenegger, before Stallone, before Seagal, Van Damme, or Willis, Charles Bronson was the ultimate movie tough guy. But if there is one thing more testosterone-saturated than a Charles Bronson movie, it’s a Charles Bronson movie trailer. We decided to collect all this testosterone and concentrate it into one ultimate Charles Bronson movie trailer…

And in case it seems like this could all be from one movie, we can tell you that this montage utilizes trailers from 27 different films over the span of 39 years. Charles Bronson, the one and only.

Do recent polls really spell certain victory for Bruce Rauner?

As the end of the summer heats up, so does the end of the Illinois’ governor’s race. In the political polls conducted so far, the Republican challenger Bruce Rauner seems to be leading Democratic Gov. Pat Quinn, but the margins vary based on polling entity. Two Reboot Illinois/We Ask America polls had Rauner winning by 10 and 14 percentage points, but CBS/New York Times, Harstad Strategic Research and Rasmussen Reports polls showed him ahead by only a few percentage points. On the other hand, a Chicagon Sun-Times/We Ask America poll had Rauner ahead, leading by 13 points.

Why such large margins of differences?

Even as we conducted our own polls, we’ve consistently cautioned that polling represents a snapshot in time. It’s a measure of the attitudes of a random pool of respondents on the day they’re surveyed. Check out graphs on Reboot Illinois that show the differences between polls from several organizations based on timing and the particular sample pools that each poll captured.

Despite such varied margins of a lead, the polls still present a compelling argument for a Rauner victory in November. But Madeleine Doubek said it’s still too early to call Quinn toast. He is a well-established political player in the state. In those same polls, Quinn was generally ahead in Chicago, where a significant portion of Illinois voters come from on Election Day, meaning things could swing the other direction fast. Plus, many non-binding ballot questions in Chicago and across the state about the minimum wage, birth control and gun control may persuade Democratic-leaning voters to come out.

Of course, Rauner’s campaign also has been busy spending millions on political ads that could counteract Democratic efforts. At this point, anything could happen.

6 Tips About Breakthrough Drugs: For Example, Should Breast Cancer Patients Try to Get Palbociclib?

Breakthrough drugs are widely covered in the media. After hearing about these new drugs, patients and their families are always asking me how they can get access to the new medicine or participate in a clinical trial of the new drug. Let’s look at a current example.

Widespread breast cancer is a serious incurable problem. But with hormonal therapy such as tamoxifen or aromatase inhibitors (like letrozole), it has turned into a chronic disease that patients can live with for several years. However, patients become resistant to tamoxifen or aromatase inhibitors and must then proceed on to other treatments including hormonal medications, chemotherapy or radiation therapy.

Any new advance that can lead to longer and better life for these women surely must represent a breakthrough. Now new results suggest that a new pill, palbociclib, might be an important advance.

Because of very impressive results, this drug has been given breakthrough designation by the FDA. If the encouraging results continue, will the drug be a breakthrough, or will it be just a small improvement?

In the most recent study reports, women who took either the daily oral standard drug letrozole plus a palbociclib pill for three weeks out of every monthly cycle had control of the cancer for twice as long as patients on letrozole alone! However, survival of the patients was not significantly longer on palbociclib (but the final results are not yet in).

Were there any side effects? Thirteen percent of the women taking the new drug with letrozole dropped out of the study, compared to only 2 percent of women on letrozole. A side effect fatigue may have accounted for this difference. Fatigue is one of the worst side effects because it is so difficult to manage and reduces a person’s quality of life.

Another factor to consider is: What will this drug cost patients? If it is approved by the FDA (and I hope the results continue to be this good or better and that it will be approved), and if it were to cost about $10,000 per month (like so many of the new cancer fighting drugs are costing), many of my patients would not be able to afford this medicine or might be poorly compliant with taking it.

What are my tips for you about breakthrough drugs?

• When you hear about a new drug for your condition, write down the name, search for it on the Internet to learn more, and then ask your physician about it.

• Ask your physician about access to clinical trials. These studies can provide patients with access to a new drug before the FDA approves it and before it becomes widely available. For more information about clinical trials and how to get into them, see my book Surviving American Medicine.

• If a new drug is approved, search the Internet to learn about side effects and patients’ comments about using the drug. Then discuss them with your doctor to get the risks and benefits as they apply to you and your condition.

• If you want to take a new drug, but the price is very high, ask your doctor and your pharmacist if they know of discounts or free drug that can be made available to you by the drug manufacturer, or by foundations that can help patients. Do not be embarrassed to ask! Some companies provide help or free drug even if your income is over $100,000 per year. If they do not know, contact the drug manufacturer or look up information on their website.

• Continue to be encouraged and optimistic about new breakthrough drugs. I will highlight many of them in my blog, but your awareness of them can help you and friends or family challenged by serious disease to get up-to-date treatments with better outcomes.

So I truly hope that with these tips you can have access to any new drug that can help your condition. I hope palbociclib and many other new anti-cancer drugs will continue to give good results, be approved by the FDA, and be affordable to all patients who need them.

Dr. Presant has no relationship with any company that manufactures any drug mentioned in the article.

Science Academy Falters in Launch of New GE Study

2014-08-09-GEstudyPioneer_maize_.jpg

One morning a few weeks ago, I received an email from the National Academy of Sciences’ National Research Council (NRC), announcing the makeup of a provisional committee of experts that has been tasked with carrying out a comprehensive new study of genetically engineered (GE) crops. This study is supposed to assess the history of GE crops around the world, the diverse experiences of farmers in different countries and a wide range of “purported” negative and positive impacts of GE seeds and their associated technologies (for example, pesticides).

Done right, this could be an illuminating investigation, right? But as I looked over the bios provided on NRC’s webpage, I quickly realized that the Council appears to have a pretty poor idea of how to carry out such a challenging, complex and multifaceted study. In fact, this week 67 scientists and researchers publicly rebuked the NRC for failing, right at the outset, to put together a slate of experts equipped for the task.

Gaps in Expertise

The majority of the NRC panelists are biophysical scientists, no doubt highly skilled in what they do. Most have training in fields such as molecular biology, genetics, genomics, biochemistry, plant biotechnology, crop sciences and plant breeding. Several have spent a significant portion of their careers working within a GE-crop-development framework. There are a handful of others: a communications specialist who worked in public relations and marketing, an agricultural economist, and a couple of lawyers. (One has a relevant background in international law and human rights.) And, on this panel of 19, there is one sociologist. Just one.

As currently configured, NRC’s panel has nowhere near the scholarly or real-world expertise required to produce a credible product.

Now, remember, this panel is supposed to assess the history and impacts of GE crops on real people: on farmers and rural communities in countries around the world. I looked again over the list of experts. (Maybe I missed something.) Where were the rural and development sociologists, political economists, political ecologists, anthropologists, geographers, international development experts with real-world experience in community-based participatory research? Where were the public-health professionals, with expertise in occupational, environmental and community health? Where were those trained in multidisciplinary research and complex systems science? Where were those who understand and study agriculture as a complex, continually evolving social/cultural/ecological system?

I also noticed the paucity of women (just four!) — and the glaring absence of a single farmer on a panel tasked with assessing the experiences of… farmers!

Biotech Bias?

Meanwhile, another group of scientists and researchers criticized NRC for failing to diversify the range of institutional interests represented on the panel. Several of the panelists come from the biosafety and biotechnology support programs of USAID and USDA, and the Monsanto-affiliated Donald Danforth Plant Science Center — institutions that, as the letter says, are “devoted to the research, development, commercialization, export and/or trade in GE crops.”

NRC committee members are supposed to serve as individuals, leaving behind the interests of their home institutions. That’s fine to say and makes sense in theory. But in reality, how we think, the kinds of questions we ask and how we go about answering them are all inevitably influenced not only by disciplinary background but also by the assumptions of our professional community, the orientation of our institutional “homes” and a host of other sociocultural factors. (That recognition, by the way, and a commitment to including a diversity of disciplines and institutional perspectives, as well as equitable gender and geographic representation, is in part what made the UN-sponsored IAASTD report so unique among evidence-based assessments.)

Transparency, Please

I am also troubled by the lack of clarity and transparency that surrounds the study. Despite a partial commitment to transparency at certain stages of the review process, many things remain opaque. What are the origins of this study? Who are its sponsors? Who at NRC decided on committee participant invitations? And as the study gets underway, how will minority perspectives and dissenting opinions be treated?

NRC states that the final product will be a consensus report. In my experience, this usually results in a watered-down report that presents only the lowest common denominator of what everyone can agree on.

Far more useful — particularly in a study of a highly controversial topic such as GE crops — would be an unflinching, honest presentation of the plurality of opinions and differing interpretations of evidence that exist. This would better reflect and help us to understand the very real tensions (and their causes) among scientists, farmers and the public at large about how best to achieve the food system we want.

Asking the Wrong Questions

Perhaps the most troubling feature of this new GE study is that NRC appears to be asking the wrong questions in the wrong way. The study takes as its starting (and ending) point the question of GE crops and asks how this technology might contribute to agricultural innovation.

A far more useful approach would be to step back and ask: What are the challenges facing agriculture today? What do we need to know and understand in order to transform our agrifood system into one that is equitable, resilient and sustainable? (Hint: The IAASTD already asked those questions, and with over 400 authors from 80 countries, they did an excellent job at answering them.)

Many of the solutions to today’s agrifood-system challenges will be social, economic and political. Some may have a technological component. The problem with NRC’s approach is that asking how one technology can address a very complex array of mostly nontechnical issues — and then looking at it in isolation from other possible solutions — can become a self-limiting exercise.

Public Input?

To be fair, NRC appears to be making an effort to open its doors to public engagement. The agency offered a 20-day comment period on its provisional committee slate (now closed). There will be several committee meetings over the course of the study that are open to the public, with the first taking place in Washington, D.C., on Sept. 15 and 16. And anyone can recommend experts to present to the committee. But what NRC will do with this public feedback is anybody’s guess.

Unless things change radically and fast, this NRC study appears destined (or designed?) to produce just another myopic “what could go wrong” endorsement of the biotech industry’s products. That outcome would be a missed opportunity by the Council to provide the public and policymakers with a truly meaningful, nuanced and illuminating report. Surely our National Academy of Sciences can do better.

Middle (ST)AGE, Middle Age. Acceptance is Key! (Part 1)

Now that we’re friends, let’s take a little stock here. I know you. Or folks like you. You’re busy!! You’ve been running your life race with commitment. Your head down, steadily plowing forward, constantly moving towards that ever elusive, but ever present THING that we all want.

Let’s face it. You’ve been at this race for awhile now. It really kicked into high gear when you started out on your own, or were trying to “grow up” around the age of 17 or 18. And that was a long, LONG time ago.

For some people, it takes them well beyond this time. Heck, they’re still living with their mother and drooling on the basement pillows well into their thirties, but, I digress.

Slackers aside, most of us try to do the best we can from the moment we wake up into our lives and accept that the only person who can make our life happen is us. Me. You. Numero Uno!

Over the years, we do for others every day with our heads down, fighting the fight for the greater good. Our intentions drive us. Intending to make a dollar. Intending to do as little harm as possible. Intending to help. Some folks just intending to keep their heads above water, intending to fend off the wolves.

The basic motivation, whether squeaking by, or living with a bit more luxury, is simply survival.

With all the advancements in this computer driven, technologically advanced world of ours, the basic driving force for every single human and every single animal is the same.

Time marches on (all over our face) as we are all just living. Most giving very little thought to where it is we are right now in the moment. Who has the time to acknowledge time?! We have been too busy raising kids, getting promotions, walking the dog, dealing with the PTA, mowing the lawn…

Then one day,

(cue JAWS theme music in your head)

Something is different.

You find yourself looking at friends, and commenting on how old THEY look. Wait a minute, you went to High School with them. And of course you notice how much better you look than them! Maybe you just attended your twentieth high school reunion? Or maybe it was your thirtieth, or even fortieth?

Then you look to your parents, if you’re lucky enough to still have them. How much older they are than the last time you really payed attention. They’re what? They’re looking at assisted living situations?

Well, that just can’t be.

You take a good look at your kids, if you have them, and you realize how grown up they are. They’re telling you to expect a card on Grandparents Day this year.

Grandparent? You?

Well, if all of this is true, that your friends are older, your parents are older, your kids are older, you’re going to be a grandparent? Clearly, something is different about you.

BAM.

It hits you like a ton of bricks.

You’re not dense. You’ve always known that two plus two equals four. Time passes.Things change…

You can do it. Admit it. Take a sip of water. Breathe in and say it with me:

I’M MIDDLE AGED!

(now watch Season 1, Episode 1 of Middle (ST)age. You’ll feel better about yourself!

Marina Lippon, Actress:

Middle (ST)age is written by Stacia Fernandez and Jacob Pinion and can be seen in it’s entirety on Stage17.tv. Follow Stacia at @Fernandezstacia — follow her character Marina Lippon at @MarinaLippon or follow her page MIDDLESTAGE on Facebook. ust don’t follow her around the grocery store. It makes her nervous.

Chasing Your Big Idea Won't Lead to Success

For much of my life, I’ve chased after the “big idea”, or in other words, the one idea that would save me from insignificance and anonymity. If you’re reading this, you’ve probably felt the urge to find your big idea too.

But, I’m starting to think this is a lie.

What if there is no big idea?

What if we’re wasting our time going in search of an illusion?

It wasn’t until recently that I found out I was.

Truth is, a big idea isn’t as big as we imagine it to be.

If you think about the iPhone, you would think it’s a big idea. The iPhone has completely revolutionized the phone market. But if you analyze it closely, zoom in on what innovation actually happened, you would see that Apple didn’t create the phone. In fact, when people heard that Apple was entering into the phone market, many of them shrugged their shoulders. They didn’t care. The phone already existed, but they’re big idea was simply improving on what already existed.

So often we imagine success to come once we innovate, come out with something completely new. But our “big ideas” aren’t always new things.

Our big ideas are sometimes improving on simple ones.

But if you ask others what success looks like, they would most likely tell you that success follows coming out with something new. You can’t blame them. We’ve been primed through our history classes that success looks like Thomas Edison discovering the lightbulb and Henry Ford making the automobile.

Not only that, but we have a certain lens that can only see the finished product, not the hard work it took to arrive upon that idea. If we could see the hard work, we would find that successful people most often didn’t come up with something entirely new.

Instead, they rummaged through a number of simple ideas until it formed the path to their big idea.

This is how big ideas are. Our big ideas are built off of a culmination of many simple ideas.

For instance, the success of Guy Laliberté’s Cirque de Soleil began from a simple performing troupe of clowns. Laliberté didn’t all of a sudden wake up with this idea of having the largest theatrical production in the world. His big idea was built off the simple idea he was currently executing.

Our big ideas are comprised of the many simple actions we choose today.

If you’re in a start-up company that appears like a simple idea, don’t worry that it didn’t start out as being big. Instead, dream higher. See what simple things you can improve on today. And after a while, you’ll stumble across your innovation.

Neglecting the simple ideas won’t form your innovation. Your innovation will come from improving simple ideas.

That might not be how we envision success, but to see success coming from an utterly new idea would cripple us from not doing anything significant at all.

Deny the illusion of having a big idea. Search for it through the simple ideas around you, and you’ll find the treasure you’re looking for.

This post was originally featured on nealsamudre.com.

You Can Posses Zoe Saldana in Action Figure Form with this Gamora Collectable

If you are one of the hordes of fans of the hit summer flick Guardians of the Galaxy, you may have secretly wished you could get up close and personal Zoe Saldana, who plays Star-Lord’s green crush Gamora in the film. Hot Toys has unveiled a fantastically detailed action figure of Gamora that uses an exceptionally accurate reproduction of Zoe from the film.

guardians of the galaxy gamora figure 1 620x434magnify

This 1/6th scale, handpainted collectible has 28 points of articulation and has interchangeable palms for different fighting styles. The statue is so realistic it almost looks like a photo of her standing in costume from the movie.

guardians of the galaxy gamora figure 10 300x250
guardians of the galaxy gamora figure 2 300x250
guardians of the galaxy gamora figure 9 300x250
guardians of the galaxy gamora figure 8 300x250
guardians of the galaxy gamora figure 7 300x250
guardians of the galaxy gamora figure 6 300x250
guardians of the galaxy gamora figure 5 300x250
guardians of the galaxy gamora figure 4 300x250
guardians of the galaxy gamora figure 13 300x250
guardians of the galaxy gamora figure 11 300x250
guardians of the galaxy gamora figure 3 300x250
guardians of the galaxy gamora figure 12 300x250

You can pre-order the action figure now for $199.99(USD) and it is expected to ship next April. This would be the perfect addition to go alongside the Rocket Raccoon and Groot statues we talked about not long ago.

[via Nerd Approved]

This Cyborg Arm Is the First Step to a Badass Lego Mech Suit

This Cyborg Arm Is the First Step to a Badass Lego Mech Suit

At some point in your nerdy childhood, you surely imagined what it would be like to build an entire exoskeleton out of Lego. How much fun would that be to have a Lego creation you could actually climb inside and drive around?! Well, award-winning Lego enthusiast Diavo Voltaggio is well on his way to that bright future.

Read more…